Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer
Go back to Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer| AGENUS (NASDAQ: AGEN) | Delayed: 7.73 -0.36 (4.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.09 | 52 Week High | $7.49 | |||
| Open | $8.03 | 52 Week Low | $2.61 | |||
| Day High | $8.07 | P/E | N/A | |||
| Day Low | $7.71 | EPS | $-1.10 | |||
| Volume | 66,528 | |||||
| (NASDAQ: GANX) | Delayed: 1.97 -0.03 (1.5%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.00 | 52 Week High | $ | |||
| Open | $2.01 | 52 Week Low | $ | |||
| Day High | $2.01 | P/E | N/A | |||
| Day Low | $1.96 | EPS | $ | |||
| Volume | 45,287 | |||||
